Although meta-analyses has indicated that K-Ras gene mutations are weak prognostic markers of poorer outcome in NSCLC, results from individual studies have been inconsistent (Huncharek et al, 1999; Mascaux et al, 2005; Tsao et al, 2007). Here, KRAS is linked to non-small cell lung carcinoma.